DECODE GENETICS –

Reykjavik, Iceland

Went public on 7/18/2000 at $18 per share

Filing Range: 9.6 mil. shares @ $14 to $18

Shares Outstanding: 41.4 mil. shares

Underwriters: Morgan Stanley Dean Witter/Lehman Brothers

Company Counsel: Smith Stratton Wise Heher & Brennan

Manager Counsel: Davis Polk & Wardwell

Auditor: PricewaterhouseCoopers

The Company:

Operates a genomics company that uses human genetics to acquire new knowledge amount health and disease and using it in pharmaceutical development.

Venture Backers:

Burr, Egan, Deleage & Co.

Alta Communications

Atlas Venture

Advent International Corp.

HarbourVest Partners LLC

ARCH Venture Partners

Medical Science Partners

Polaris Venture Partners

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 08/01/1996 1 Expansion 736.0

2 09/12/1997 2 Later Stage 334.0

3 10/17/1997 8 Early Stage 3961.2

4 03/01/1998 1 Expansion 9275.0

6 03/30/1999 1 Expansion 825.0

7 08/08/1999 1 Later Stage 37500.0

Financials:

(Data in $ millions)

Y/E

12/31/99

Total Revenues: $16.4

Net Income: -23.2